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Abstract: The use of oral iron integration is commonly recommended for the treatment of iron
deficiency, nevertheless the diagnosis and treatment of this disease could clearly be improved.
The aim of this work was the synthesis of therapeutic systems, iron (II) based, by sol-gel method. In an
SiO2 matrix, we embedded different weight percentages of polyethylene glycol (PEG6, 12, 24 wt%) and
ferrous citrate (Fe(II)C5, 10, 15 wt%) for drug delivery applications. Fourier Transform Infrared (FTIR)
spectroscopy was used to study the interactions among different components in the hybrid materials.
Release kinetics in a simulated body fluid (SBF) were investigated and the amount of Fe2+ released
was detected by Ultraviolet–Visible spectroscopy (UV-VIS) after reaction with ortho-phenantroline.
Furthermore, the biological characterization was carried out. The bioactivity of the synthesized
hybrid materials was evaluated by the formation of a layer of hydroxyapatite on the surface of
samples soaked in SBF using FTIR spectroscopy. Finally, also, the potential antibacterial properties of
the different materials against two different bacteria, E. coli and P. aeruginosa, were investigated.
Keywords: sol-gel; ferrous citrate; FTIR analysis; drug release; antibacterial properties
1. Introduction
Iron is very important for many biological functions such as respiration, energy production,
DNA synthesis, and cell proliferation [1]. Several ways have been observed by the human body
to conserve iron; in fact, it is strongly regulated by different molecular mechanisms, avoiding its
accumulation to a toxic level or its deficiency [2]. Iron deficiency is considered the main cause
of anemia worldwide, [3] and it is a major health problem that is related to maternal and child
mortality [4]. The use of oral iron supplementation for the treatment of iron deficiency is usually
recommended, such as ferrous sulphate, anhydrous ferrous sulphate ferrous gluconate, and ferrous
fumarate [4], nevertheless, the diagnosis and treatment of this disease could clearly be improved.
In fact, although oral iron supplementation is the treatment of choice for the majority of patients
because of its effectiveness and safety, oral iron supplementation has disadvantages, including poor
compliance, high incidence of adverse gastrointestinal effects and high potential for interactions with
other treatments [5,6]. In the last decade, the production of new biological systems able to release iron
(II) in a controlled manner are an interesting alternative compared to systemic therapy.
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Therefore, the aim of this work was the synthesis of iron (II)-based drug delivery systems,
by sol-gel method. In an SiO2 matrix were embedded different weight percentages of polyethylene
glycol (PEG6, 12, 24 wt%) and ferrous citrate (Fe(II)C5, 10, 15 wt%) to obtain several hybrid materials.
The advantages of the use of these materials as biomedical implants, for example as prosthesis or
subcutaneous implants for local delivery in the systemic circulation of Fe2+, are the continuous release
of Fe2+, without the need to remember to take the drug daily, also, it is possible always active coverage,
because the molecule could dissolve slowly, giving a delayed effect over time. Furthermore, the use
of drug delivery system optimizes the biopharmaceutical, pharmacokinetic and pharmacodynamics
properties of a drug, reducing side-effects [6]
The sol-gel method is an interesting technique to prepare organic-inorganic hybrid materials
which involves the hydrolysis reactions of the precursor leading to the formation of a colloidal
suspension and its evolution in a gel by condensation process [7]. The main advantages of the sol-gel
techniques for the preparation of hybrid materials are the low temperatures used during the synthesis
and versatility [8]. Judenstein and Sanchez have proposed the classification of the hybrid materials
which depends of the interactions between the components. In particular, in the Class I the organic
and inorganic compounds are bond by hydrogen bonds, van der Waals, or ionic bonds; in the Class II,
the two components are linked by strong chemical bonds (covalent or polar covalent bonds) [9].
In the literature, there are many works about the silica-based materials [10–12], that describe
the high biological properties, the cell-material interactions and cell invasion due to their reaction
products [10]. The biocompatibility of silica materials has been improved with the addition of
polyethylene glycol (PEG), because the presence of the polymer improving cell adhesion and growth
for the high hydrophilicity of the materials [13–15]. PEG is used in several biomedical applications
such as drug delivery thanks to his versatility and biocompatibility [16]. Moreover, the addition of
PEG in the hybrids improve the reduction of toxicity and the extension of the circulation time of many
drug nanocarriers [17–19].
Furthermore, in silica/PEG materials has been added ferrous citrate (Fe(II)C), prepared by the
redox reaction between iron powder and citric acid, to evaluate the Fe2+ release from different materials
and, thus, the use of hybrids as systems for controlled iron release.
Fourier Transform Infrared (FTIR) spectroscopy was used to study the interactions among
different components in the hybrid materials. Release kinetics in a simulated body fluid (SBF) were
investigated and the amount of Fe2+ released was detected by UV–VIS spectroscopy after reaction with
ortho-phenantroline. In addition, the biological characterization was carried out. The bioactivity of the
different hybrids was evaluated by observing the typical peaks of hydroxyapatite on the surface of
materials, soaked in SBF, using FTIR spectroscopy. Finally, also, the potential antibacterial properties
of the different materials against two different bacteria, E. coli and P. aeruginosa, were investigated.
2. Materials and Methods
2.1. Ferrous Citrate Preparation
A total of 25 g Citric acid monohydrate (>99.5%, Fluka, Munich, Germany) were completely
dissolved in 500 mL of ultrapure water to which 6.0 g of iron powder (>99%, Sigma-Aldrich, St. Louis,
MO, USA) were added. The solution was boiled and stirred under magnetic stirring (Sigma-Aldrich,
St. Louis, MO, USA) until all iron powder disappeared and consequently appeared the ferrous citrate
complex (Fe(II)C). Then the mixture was cooled at room temperature and the precipitate grey/pearly
complex was filtered under vacuum with a paper filter and washed with water; finally, the obtained
solid was freeze dried.
2.2. Sol-Gel Synthesis of the Hybrid Materials
The hybrid materials with different percentages of polyethylene glycol (PEG, MW = 400,
Sigma-Aldrich, St. Louis, MO, USA) and Fe(II)C were synthesized by sol-gel method. Tetraethyl
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orthosilicate (TEOS; Si(OC2H5)4; Sigma-Aldrich, St. Louis, MO, USA) was used as precursor of silica
matrix and it was added in a solution of 99.8% ethanol (EtOH, Sigma-Aldrich, St. Louis, MO, USA)
and distilled water. In this study the molar ratios of solution were equal to H2O/TEOS = 26.6 and
EtOH/TEOS = 6.
Afterwards, different amount of PEG(6, 12, 24 wt%) and Fe(II)C(5, 10, 15 wt%) were solubilized in 99.8%
ethanol and distilled water under stirring at 38 ◦C, respectively. Afterwards to the gelation process,
the residual solvent was removed from the wet gels in an oven at 50 ◦C for 24 h. The Figure 1 shows
the flow chart of the hybrid synthesis.
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Figure 1. Flow chart of sol-gel synthesis.
2.3. Fourier Transform Infrared (FTIR) Analysis of the Hybrid Materials
A Prestige 21 Shimadzu (Kyoto, Japan) FTIR instrument equipped with a DTGS detector was
used to study the interactions between the different components. In the 400–4000 cm−1 region,
with resolution of 4 cm−1 (45 scans) were recorded the spectra of the materials by Fourier transform
infrared (FTIR) transmittance. KBr pelletized disks containing 2 mg of each sample and 198 mg of KBr
were made. The FTIR spectra were processed by Prestige software (IR solution, software version 1.50,
Shimadzu, Kyoto, Japan)
2.4. Study of In Vitro Release
The hybrid materials were crushed to a powder using an agate mortar (Sigma-Aldrich, St. Louis,
MO, USA) and were soaked in 10 mL of simulated body fluid (SBF) solution under continuous
magnetic stirring at 150 rpm.
The study of in vitro release is used to evaluated the amount of Fe2+ released from the materials
in function of the percentages of Fe(II)C in the hybrids.
In particular, the release of Fe2+ from different materials was assessed at different exposure time
using normative reference APAT IRSA CNR Man. 29/2003 Metodo 3160/A. In this regard, 1mL of
SBF solution with the powder was added to a solution of water, hydroxylamine hydrochloride 10%,
1,10-phenanthroline 0.1%, Acetate Sodium 10%.
Release measurements were taken by means of a Shimadzu UV-1700 Double Beam Scanning
UV-VIS Spectrophotometer (Kyoto, Japan). Absorbance values were taken at a wavelength
λ = 520.0 nm, corresponding to the absorbance of Fe2+. The release experiments were repeated three
times on each hybrid. Data are presented as means ± standard deviation for a representative experiment.
The calibration curve was determined by taking absorbance versus concentration between 0 and
4.99 mg/L as parameters. For this interval, the calibration curve fits the Lambert and Beers’ law [20]
A = ε l C = 1.265 C, (1)
where A is absorbance, ε is molar absorptivity coefficient, l is path length and C is concentration
(mg/L).
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2.5. Bioactivity Test
The simulated body fluid (SBF) solution was used for 7, 14, 21 days at 37 ◦C to study the hybrids’
bioactivity [21]. The materials powders were obtained using a mortar. The FTIR and XRD analysis were
used to evaluate the apatite formation. XRD analysis was carried out using a Philips 139 diffractometer
(Amsterdam, The Netherlands) equipped with a PW 1830 generator, tungsten lamp and Cu anode,
where the source 140 of X-ray is given by a Cu-Kα radiation (λ = 0.15418 nm). The nucleation of
biominerals on the samples could allow the depletion of the ionic species in the SBF, to overcome this
problem the solution was replaced every 2 days. The ratio between the total exposed surface and
the volume solution was chosen in agreement with the literature. After the exposure, the samples
powders were dried in a glass desiccator (Sigma-Aldrich, St. Louis, MO, USA), and then subjected to
FTIR analysis.”
2.6. Antibacterial Activity
In order to study the effect of the samples on the microbial growth, E. coli (ATCC 25922) and
P. aeruginosa (ATCC 10145) were used. E. coli was cultured in TBX Medium (Tryptone Bile X-Gluc)
(Liofilchem, Roseto degli Abruzzi, Italy), while P. aeruginosa in Pseudomonas CN Agar (Liofilchem,
Roseto degli Abruzzi, Italy).
Afterwards, the bacterial cultures were diluted in distilled water to produce a bacterial cell
suspension of 10 × 105 CFU/mL. Both bacteria were inoculated in absence and in presence of the
hybrid materials. E. coli was incubated with the materials for 24 h at 44 ◦C, while the P. aeruginosa
for 48 h at 36 ◦C. The microbial growth was evaluated by observing the diameter of the inhibition
halo (ID). The obtained values are the mean standard (SD) deviation of measurements carried out on
samples analyzed three times.
3. Results
3.1. FTIR Analysis
FTIR analysis is considered as an appropriate method to study the interactions in the hybrid
materials. The typical bands of silica matrix and polymer are visible in the hybrids’ spectra which are
shown in the Figure 2 (curve b–d). The asymmetric and symmetric Si–O–Si stretching, and bending
vibrations of the silica are attributed to the band at 1080 cm−1 with a shoulder at 1200 cm−1 and the
peaks at 800 cm−1 and 460 cm−1, respectively [22,23]. Furthermore, in the hybrid spectra, it is possible
to observe a slight shift toward lower wavenumbers of the Si–OH bond vibrations and O–H stretching
compared to pure SiO2 (curve e) from 960 to 955 cm−1 and from 3450 to 3440 cm−1 [24,25], suggesting
that an interaction between silica matrix, PEG and Fe(II)C occurred.
These interactions can be confirmed, also, by the shift of wavenumbers of some polymer peaks,
in the hybrids’ spectra, the PEG methylene C–H asymmetric stretching at 2927 cm−1 and the band of
CH2 group at 1382 cm−1 are observed, while, the same peaks, in the pure PEG spectra (curve a) at
2870 and 1350 cm−1 are recorded [26].
The presence of Fe(II)C is confirmed comparing the hybrid spectra with those of the pure Fe(II)C.
When the different amounts of Fe(II)C are added in the SiO2/PEG/Fe(II)C some bands related to
citrate are detectable with several intensity. In particular, the peaks at 1734 and 1430 cm−1 due to the
C=O stretching and COO− group, respectively, are visible as shoulder in the hybrid spectra (curve
b–d) compared to pure Fe(II)C spectra (curve f) [27,28].
Therefore, the formation of hydrogen bonds between the –OH groups of the silica matrix and
ethereal oxygen atoms (H-bond donors) or terminal –OH in the polymer chains [25,29], and, also,
the interaction with Fe(II)C were suggested by the different shape and position of the silica bands.
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Compari g the diffe e t rel ase plots (Figu e 4A–C), it is possible o observed hat t r lease of Fe2+
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A similar behavior was obs rved in the SiO2/PEG(6, 12, 24 wt%)/Fe(II)C(5 wt%) hybrids
(Figure 4A–C), despite the different amounts of polymer. Probably, the release of Fe2+ do not depend
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of polymer concentration but it might be due to a low percentage of Fe(II)C in the hybrid that allows
many interactions with silica-PEG matrix, reducing the release of Fe2+.
In the release plots (Figure 4A–C) of SiO2/PEG(6, 12, 24 wt%)/Fe(II)C(10 wt%) and SiO2/
PEG(6, 12, 24 wt%)/Fe(II)C(15 wt%) the presence of the different percentages of polymer modified the Fe2+
release curves, unlike the hybrids with Fe(II)C(5 wt%). The PEG amount equal to 24 wt% (Figure 4C)
determines a greater release of the Fe2+ compared to another one, probably due to the formation of
the silica/PEG network. In particular, when the content of PEG and Fe(II)C is higher in the hybrids,
a part of it cannot form H-bonds because all hydroxyl groups of silica are already involved in H-bonds.
Probably, the formation of few weak bonds between Fe(II) and silica-PEG matrix allow the greater
release of Fe2+ [30–32].
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Figure 4. Time-depe t r release plot for (A) SiO2/PEG6 wt%/Fe(II)C5 wt%; SiO2 PEG6 wt%/
Fe(II)C15 wt%; SiO2/PEG6 wt%/Fe(II)C20 wt%; (B) SiO2/PEG12 wt%/Fe(II)C5 wt%; SiO2/PEG12 wt%/
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3.3. Bioactivity Test
The bioactive materials are able to form an apatite layer on their surfaces in the living body,
allowing the bond to living bone. The presence of various functional groups on materials surface
induce the hydroxyapatite formation. In this regard, the hybrids were soaked in SBF for 7, 14 and 21
days to evaluate their bioactivity [21]. In particular, the interaction of Si–OH groups on the hybrids’
surface with the Ca2+ ions present in the fluid allow to the hydroxyapatite nucleation and leading
to an increase of positive surface charge. The formation of amorphous phosphate is induced by
the combination of the Ca2+ ions and negative charges of the phosphate ions, which spontaneously
transforms into hydroxyapatite [Ca10(PO4)6(OH)2] [33]. The FTIR was used to identify the typical
peaks of hydroxyapatite layer on materials surface (Figure 5). All hybrid materials showed the same
results independently of PEG and Fe(II)C content. The displacement of Si–OH band, from 960 to
970 cm−1 suggested the interaction of the hydroxyapatite layer with the –OH groups of the silica
matrix. Furthermore, comparing the hybrid materials spectra (Figure 5 curve) after 21 days in SBF
with those of the same materials not soaked in SBF (Figure 5 curve a), the split of the band at 580 cm−1
in two new ones at 575 and 560 cm−1, was visible. The presence of these new bands is caused by the
formation of the hydroxyapatite precipitate, in particular, and are due to the stretching of the hydroxyl
groups of hydroxyapatite and the vibrations of the PO3−4 groups [34,35]. Moreover, the peak related to
citrate at 1430 cm−1 attributed to COO− group, undergoes change in the intensity that might be due to
the interaction with the hydroxyapatite layer.
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Furthermore, XRD measurement was used to identify the presence of hydroxyapatite on the
hybrids’ surface. The intense peaks of hydroxyapatite crystalline are visible in Figure 6( ), confirming
that the materials surface is covered by hydroxyapatite layer after 21 days in SBF. Moreover, this result
suggest that the hydroxyapatite layer is very thick to detect XRD signals from hybrids’ surface [21,36].
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Figure 6. A representative XRD of SiO2/PEG12 wt%/Fe(II)C15 wt% soaked in SBF solution for 21 days.
3.4. Antibacterial Activity
In order to evaluate the effect of the hybrids on the microbial growth, E. coli and P. aeruginosa
were used. The different materials were grinded in a mortar to obtain powders. Both bacteria were
inoculated in absence and in presence of the 100 mg of hybrids’ powders. The zones of inhibition
formed by the materials without Fe(II)C and containing different amount of Fe(II)C against E. coli are
shown in Figure 7A. It is possible to observed that the materials exhibited mild activity against E. coli,
only the SiO2/PEG6 wt%/Fe(II)C15 wt% hybrid induces the inhibition halo around the synthesized
hybrid Figure 7C. These results suggest that the microbial growth was inhibited by higher amount
of Fe(II)C and by low percentage of PEG. When the P. aeruginosa was inoculated in presence of all
the hybrids, the inhibition halo was more visible (Figure 7B). In particular, the diameter of zone of
inhibition (Figure 7C) increases with 10 and 15 wt% of Fe(II)C, independently of the polymer content.
Furthermore, the pigmentation reddish brown of P. aeruginosa inoculated with the hybrids containing
Fe(II)C is observed (Figure 7B). In literature is reported that P. aeruginosa is able to produce a range of
pigments under certain growth conditions [37–39]. Probably, the pigmentation reddish brown it is due
to the production of pyomelanin which is involved in iron reduction and acquisition [40], resistance to
oxidative stress [41] and virulence [38]. The pyomelanin could be produced by the release of Fe2+ from
hybrids as this phenomenon is not observed with materials without Fe(II)C. Finally, in the Figure 7C
are reported the inhibition zones of E. coli and P. aeruginosa. Comparing the diameter of the inhibition
zones of the different hybrids, the better antibacterial activity against P. aeruginosa was observed.
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with all material ; ) omparison of inhibition zone of E. coli and P. aeruginosa for all materials.
Values are the mean SD of measur rried out on samples analyzed three times. Th means and
S.D. are shown. *, p <0.05 vs the bacteria control treat d with hybrids without Fe(II)C or vs t bacteria
treated with hybrids containing Fe(II)C.
4. Conclusions
In the present study, the different percentage of Fe(II)C and PEG were added in the silica matrix
by sol-gel method. FTIR spectra of the obtained hybrids, show all bands of citrate, and also, the typical
peaks of polymer and silica. Therefore, the different shape and position of some bands confirm the
formation of H-bonds between the inorganic matrix, the PEG chains and, also, the interaction with
Fe(II)C. The release of Fe2+ from hybrids was studied. Comparing all materials, those containing
24 wt% of PEG determine a greater release of the Fe2+. This result might be due to the high content
of PEG and Fe(II)C, that doesn’t allow a part of it to form H-bonds b cause all hydroxyl g oups of
silica are already involved in weak bonds. Furthermore, the FTIR analysis after 21 days in SBF has
sugg st th t the y rids are bioactive, and the presence of Fe(II)C or polymer does not affect the
bioactivity of silica matrix. Finally, E. coli and P. aeruginosa were inoculated with the different hybrid
materials to evaluate their antibacterial activity. The materials exhibited mild activity against E. coli
compared to P. aeruginosa. In particular the diameter of zone of inhibition of P. aeruginosa increases
with 10 and 15 wt% of Fe(II)C, independently of polymer content. In conclusion the obtained hybrid
materials could be used as biomedical implants to release different controlled amount of Fe2+ in
the systemic circulation, without going through the gastrointestinal track, in order to allow active
Materials 2018, 11, 2270 10 of 11
coverage. Obviously, these hybrid materials will be investigated further to confirm and extend the
obtained results.
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